Flow cytometric assays of anticancer drug resistance.
Hedley
D W
DW
Department of Medicine, Ontario Cancer Institute/Princess Margaret Hospital, University of Toronto, Canada.
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D001943:Breast Neoplasms; D002352:Carrier Proteins / Q000378:metabolism; D004260:DNA Repair; D004250:DNA Topoisomerases, Type II / Q000378:metabolism; D004351:Drug Resistance; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D008562:Membrane Glycoproteins / Q000378:metabolism; D014407:Tumor Cells, Cultured
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D002352:Carrier Proteins; D008562:Membrane Glycoproteins; D004250:DNA Topoisomerases, Type II; D005978:Glutathione